Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis.
Laura C CoatesChristopher T RitchlinLaure GossecPhilip S HelliwellProton RahmanAlexa P KollmeierXie L XuMay ShawiChetan S KaryekarChristine ContréWim NoëlShihong ShengYanli WangStephen XuPhilip J MeasePublished in: Rheumatology (Oxford, England) (2022)
NCT03162796; NCT03158285.
Keyphrases